Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4DM testosterone for prevention of type 2 diabetes in at-risk men
ACTRN12612000287831Phase 3Completed
- Sponsor
- University of Adelaide
- Start
- Feb 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and prediabetes comparing Testosterone undecanoate + lifestyle program with Placebo + lifestyle program (2 arms). Primary endpoints: 2-hour glucose in non-diabetic range at 2 years and Change in 2-hour glucose. Started Feb 2013; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
type 2 diabetes mellitus (T2DM)prediabetes
Beyond the preview
Go deeper on ACTRN12612000287831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000287831.